Patents by Inventor Hidekazu Nakabayashi

Hidekazu Nakabayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030104621
    Abstract: The present invention relates to a method of expressing a heterologous gene in mammalian cells and a recombinant DNA construct for use in the method. The invention also relates to a method of specifically killing cells which constitutively express AFP.
    Type: Application
    Filed: April 9, 2001
    Publication date: June 5, 2003
    Inventors: Taiki Tamaoki, Hidekazu Nakabayashi
  • Patent number: 5843776
    Abstract: The present invention relates to a method of expressing a heterologous gene in mammalian cells and a recombinant DNA construct for use in the method. The invention also relates to a method of specifically killing cells which constitutively express AFP.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 1, 1998
    Assignee: University Technologies International, Inc.
    Inventors: Taiki Tamaoki, Hidekazu Nakabayashi
  • Patent number: 5827686
    Abstract: The present invention relates to a method of expressing a heterologous gene in mammalian cells and a recombinant DNA construct for use in the method. The invention also relates to a method of specifically killing cells which constitutively express AFP.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: October 27, 1998
    Assignee: University Technologies International, Inc.
    Inventors: Taiki Tamaoki, Hidekazu Nakabayashi
  • Patent number: 5807738
    Abstract: The present invention relates to a method of expressing a heterologous gene in mammalian cells and a recombinant DNA construct for use in the method. The invention also relates to a method of specifically killing cells which constitutively express AFP.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 15, 1998
    Assignee: University Technologies International, Inc.
    Inventors: Taiki Tamaoki, Hidekazu Nakabayashi
  • Patent number: 5804407
    Abstract: The present invention relates to a method of expressing a heterologous gene in mammalian cells and a recombinant DNA construct for use in the method. The invention also relates to a method of specifically killing cells which constitutively express AFP.
    Type: Grant
    Filed: November 4, 1993
    Date of Patent: September 8, 1998
    Assignee: University Technologies International, Inc.
    Inventors: Taiki Tamaoki, Hidekazu Nakabayashi